Primary central nervous system lymphoma in the elderly: A multicentre retrospective analysis

British Journal of Haematology

Volumn 151, Issue 2, 2010, Pages 179-184

  Schuurmans, Mascha ^a   Bromberg, Jacoline E C ^a   Doorduijn, Jeanette ^a   Poortmans, Philip ^b   Taphoorn, Martin J B ^c   Seute, Tatjana ^d   Enting, Roelien ^e   Van Imhoff, Gustaaf ^e   Van Norden, Yvette ^a   Van Den Bent, Martin J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Bernard Verbeeten Institute for Radiotherapy   (Netherlands)

^c MC Haaglanden ^*  (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

age; central nervous system lymphoma; chemotherapy; performance status; radiotherapy

Indexed keywords

CARMUSTINE; DEXAMETHASONE; METHOTREXATE; TENIPOSIDE;

AGED; ARTICLE; BLOOD TOXICITY; BRAIN DISEASE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; DRUG WITHDRAWAL; FEMALE; HUMAN; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; OVERALL SURVIVAL; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEPSIS; TOXIC EPIDERMAL NECROLYSIS;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CENTRAL NERVOUS SYSTEM NEOPLASMS; COMBINED MODALITY THERAPY; EPIDEMIOLOGIC METHODS; HUMANS; LYMPHOMA, NON-HODGKIN; METHOTREXATE; MIDDLE AGED; PROGNOSIS; TREATMENT OUTCOME;

EID: 77957374105     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08328.x     Document Type: Article

References (22)

1. Abrey, L., Ben-Porat, L., Panageas, K.S., Yahalom, J., Berkey, B., Curran, W., Schultz, C., Leibel, S., Nelson, D., Mehta, M. DeAngelis, L.M. (2006) Primary central nervous system lymphoma: the Memoraial Sloan-Kettering Cancer Center prognostic model. Journal of Clinical Oncology, 24, 5711 5715.
2. Batchelor, T. Loeffler, J.S. (2006) Primary CNS lymphoma. Journal of Clinical Oncology, 24, 1281 1288.
3. Bessell, E.M., Hoang-Xuan, K., Ferreri, A.J. Reni, M. (2007) Primary central nervous system lymphoma: biological aspects and controversies in management. European Journal of Cancer, 43, 1141 1152. (Pubitemid 46590731)
4. Blay, J.Y., Conroy, T., Chevreau, C., Thyss, A., Quesnel, N., Eghbali, H., Bouabdallah, R., Coiffier, B., Wagner, J.P., Le Mevel, A., Dramais-Marcel, D., Baumelou, E., Chauvin, F. Biron, P. (1998) High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. Journal of Clinical Oncology, 16, 864 871.
5. DeAngelis, L., Seiferheld, W., Schold, S., Fisher, B. Schultz, C. (2002) Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: radiation Therapy Oncology Group Study 93-10. Journal of Clinical Oncology, 20, 4643 4648.
6. Ekenel, M., Iwamoto, F.M., Ben Porat, L.S., Panageas, K.S., Yahalom, J., DeAngelis, L.M. Abrey, L.E. (2008) Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy. Cancer, 113, 1025 1031.
7. Ferreri, A.J.M., Blay, J.Y., Reni, M., Pasini, F., Spina, M., Ambrosetti, A., Calderoni, A., Rossi, A., Vavassori, V., Conconi, A., Devizzi, L., Berger, F., Ponzoni, M., Borisch, B., Tinguely, M., Cerati, M., Milani, M., Orvieto, E., Sanchez, J., Chevreau, C., Dell'Oro, S., Zucca, E. Cavalli, F. (2003) Prognostic scoring system for primary CNS lymphomas:the international extranodal lymphoma study group experience. Journal of Clinical Oncology, 21, 266 272.
8. Hoang-Xuan, K., Taillandier, L., Chinot, O., Soubeyran, P., Bogdhan, U., Hildebrand, J., Frenay, M., De Beule, N., Delattre, J.Y. Baron, B. (2003) Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenterphase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group. Journal of Clinical Oncology, 21, 2726 2731.
9. Hottinger, A.F., Deangelis, L.M., Yahalom, J. Abrey, L.E. (2007) Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma. Neurology, 69, 1178 1182.
10. Illerhaus, G., Marks, R., Muller, F., Ihorst, G., Feuerhake, F., Deckert, M., Ostertag, C. Finke, J. (2009) High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study. Annals of Oncology, 20, 319 325.
11. Jahnke, K., Korfel, A., Martus, P., Weller, M., Herrlinger, U., Schmittel, A., Fischer, L., Thiel, E. On behalf of the German Primary Central Nervous System Lymphoma study Group (G-PCNL-SG) (2005) High-dose methotrexate toxicity in eldely patients with primary central nervous system lymphoma. Annals of Oncology, 16, 445 449. (Pubitemid 40458322)
12. Laack, N.N., Ballman, K.V., Brown, P.B. O'Neill, B.P. (2006) Whole-brain radiotherapy and high-dose methylprednisolone for elderly patients with primary central nervous system lymphoma: results of North Central Cancer Treatment Group (NCCTG) 96-73-51. International Journal of Radiaton Oncology Biology and Physics, 65, 1429 1439.
13. Nelson, D.F., Martz, K., Bonner, H., Nelson, J.S., Newall, J., Kerman, H.D., Thomson, J.W. Murray, K.J. (1992) Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG)-RTOG 8315 International Journal of Radiaton Oncology Biology and Physics, 23, 9 17.
14. Ng, S., Rosenthal, M.A., Ashley, D. Cher, L. (2000) High-dose methotrexate for primary CNS lymphoma in the elderly. Neuro-Oncology, 2, 40 44.
15. Nguyen, P.L., Chakravarti, A., Finkelstein, D.M., Hochberg, F.H., Batchelor, T.T. Loeffler, J.S. (2005) Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma. Journal of Clinical Oncology, 23, 1507 1513.
16. Omuro, A.M.P., Ben-Porat, L.S., Panageas, K.S., Kim, A.K., Correa, D.D., Yahalom, J., DeAngelis, L.M. Abrey, L.E. (2005) Delayed neurotoxicity in primary central nervous system lymphoma. Archives of Neurology, 62, 1595 1600.
17. Omuro, A.M.P., Taillandier, L., Chinot, O., Carnin, C., Barrie, M. Hoang-Xuan, K. (2007) Temozolamide and methotrexate for primary central nervous system lymphoma in the elderly. Journal of Neuro-Oncology, 85, 207 211. (Pubitemid 47629402)
18. Panageas, K.S., Elkin, E.B., Ben-Porat, L., DeAngelis, L.M. Abrey, L.E. (2007) Patterns of treatment in older adults with primary central nervous system lymphoma. Cancer, 110, 1338 1344.
19. Pels, H., Schmidt-Wolf, I.G., Glasmacher, A., Schulz, H., Engert, A., Diehl, V., Zellner, A., Schackert, G., Reichmann, H., Kroschinsky, F., Vogt-Schaden, M., Egerer, G., Bode, U., Schaller, C., Deckert, M., Fimmers, R., Helmstaedter, C., Atasay, A., Klockgether, T. Schlegel, U. (2003) Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy. Journal of Clinical Oncology, 21, 4489 4495. (Pubitemid 46594018)
20. Poortmans, P.M., Kluin-Nelemans, H.C., Haaxma-Reiche, H., Van't Veer, M., Hansen, M., Soubeyran, P., Taphoorn, M., Thomas, J., Van den Bent, M., Fickers, M., Van Imhoff, G., Rozewicz, C., Teodorovic, I. Van Glabbeke, M. (2003) High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962. Journal of Clinical Oncology, 21, 4483 4488.
21. Shibamoto, Y., Ogino, H., Hasegawa, M., Suzuki, K., Nishio, M., Fujii, T., Kato, E., Ishihara, S., Sougawa, M., Kenjo, M., Kawamura, T. Hayabuchi, N. (2005) Results of radiation monotherapy for primary central nervous system lymphoma in the 1990s. International Journal of Radiaton Oncology Biology and Physics, 62, 809 813. (Pubitemid 40779773)
22. Wassenberg, M.W., Bromberg, J.E., Witkamp D., Terhaard, C.H. Taphoorn, M.J. (2001) White matter lesions and encephalopathy in patients treated for primary central nervous system lymphoma. Journal of Neuro-Oncology, 52, 73 80.